- Investing.com
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Digital Health Pionee | OptimizeRx leads in EHR-integrated pharmaceutical messaging, showcasing strong financial performance and strategic shifts towards subscription-based models |
Market Dynamics | Explore the company's navigation of DTC challenges and its potential for growth in an evolving digital healthcare landscape |
Financial Outlook | Delve into OptimizeRx's raised 2025 guidance, with revenue projections between $101-106 million and adjusted EBITDA of $13-15 million |
Analyst Perspectives | Discover varied analyst views on OptimizeRx's future, with price targets ranging from $6 to $14, reflecting diverse opinions on the company's growth potential |
Metrics to compare | OPRX | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipOPRXPeersSector | |
---|---|---|---|---|
P/E Ratio | −34.0x | −0.9x | −0.5x | |
PEG Ratio | −0.72 | −0.01 | 0.00 | |
Price/Book | 2.8x | 1.6x | 2.6x | |
Price / LTM Sales | 3.2x | 1.1x | 3.2x | |
Upside (Analyst Target) | 5.1% | 28.1% | 38.8% | |
Fair Value Upside | Unlock | 28.7% | 5.4% | Unlock |